FIREBRICK PHARMA LIMITED - Corporate Spotlight

3.08%

6.3¢

Market Cap $15.02M

Healthcare Drug Manufacturers - Major

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.3¢		Change -0.002(3.08%)		Mkt cap ! $15.02M

Open	High	Low	Volume
6.4¢	6.4¢	6.3¢	16.26K

Buyers (Bids)

Vol.	Price($)
506	6.3¢

Sellers (Offers)

Price($)	Vol.
6.4¢	100000

Last trade - 14.04pm 12/02/2026 (20 minute delay)

FRE (ASX) Chart

FIREBRICK PHARMA LIMITED - Corporate Spotlight

Corporate SpotlightNot Yet Available

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available